TwinStrand Biosciences TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement The company argued in its complaint that Guardant's liquid biopsy assays have willfully infringed its patented duplex sequencing technology. TwinStrand Biosciences Raises $50M in Series B Round The company is commercializing an error-reducing duplex sequencing technology that can identify ultra-low frequency genomic variants. TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications Premium Since the commercial launch of its technology last year, the firm has been validating it in studies with academic groups and pharmaceutical companies. Foundation Medicine Licenses Mutation Detection Technology From TwinStrand Biosciences TwinStrand's duplex sequencing correction technology can detect ultra-low frequency DNA mutations that are otherwise often obscured by technical noise. TwinStrand Biosciences Closes $16M Series A Round The University of Washington spinout will use the funding to commercialize duplex sequencing technology to detect low-frequency DNA mutations. Jul 25, 2018 TwinStrand Targets Toxicity Testing, Cancer Diagnostics for Sequencing Error Correction Tech Premium Aug 21, 2012 UW Team Says 'Duplex Sequencing' Method Offers Millions-Fold Improvement in Error Rate Premium Breaking News DNAe, Imperial College London, U of Leicester to Develop NGS-Based Breast Cancer Monitoring Test Illumina, Israel Ministry of Health to Pilot Genome Sequencing for Diagnosing Critically Ill Infants GenomSys Gains CE Mark for New Genomic Analysis Software Thermo Fisher Scientific Q3 Revenues up 9 Percent BTIG Initiates Coverage of LumiraDx With Buy Rating Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms The Scan Panel Recommends Pfizer-BioNTech Vaccine for Kids CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old. Sharing How to Make It Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times. Bring it Back In Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray. Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.